ARCHIVES

Studies Test New Agents Offering Relief From Treatment-Related Side Effects

This article is from The Cancer Letter archive.

Vol. 27 No. 7 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

M. D. Anderson Buys Record System For In-Patient Services From Atlanta Firm.

May 4, 2001

NCI Unveils Checklist for Omics Studies

February 7, 2013

Colorectal Cancer Screening Programs Could Cut Future Treatment Costs

September 25, 2009

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005